Vertex Pharmaceuticals Incorporated shares owned by National Asset Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by National Asset Management
from 13F filings
Historical chart of National Asset Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by National Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by National Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.8M | 9.3k | 406.88 |
| 2023-09-30 | $3.3M | 9.4k | 347.72 |
| 2023-06-30 | $3.6M | 10k | 351.89 |
| 2023-03-31 | $3.2M | 10k | 315.06 |
| 2022-12-31 | $4.6M | 16k | 288.77 |
| 2022-09-30 | $4.8M | 17k | 289.57 |
| 2022-06-30 | $4.4M | 16k | 281.83 |
| 2022-03-31 | $4.2M | 16k | 261.00 |
| 2021-12-31 | $2.6M | 12k | 219.65 |
| 2021-09-30 | $3.1M | 17k | 184.47 |
| 2021-06-30 | $3.2M | 16k | 203.60 |
| 2021-03-31 | $4.5M | 15k | 300.00 |
| 2020-12-31 | $2.9M | 12k | 236.37 |
| 2020-09-30 | $3.5M | 13k | 276.97 |
| 2020-06-30 | $2.7M | 9.5k | 290.40 |
| 2020-03-31 | $1.9M | 8.0k | 238.08 |
| 2019-12-31 | $1.2M | 5.4k | 218.97 |
| 2019-09-30 | $582k | 3.4k | 169.59 |
| 2019-06-30 | $479k | 2.6k | 183.61 |
| 2019-03-31 | $643k | 3.5k | 183.98 |
| 2018-12-31 | $602k | 3.3k | 181.82 |
| 2018-09-30 | $614k | 3.2k | 193.00 |
| 2018-06-30 | $557k | 3.3k | 170.99 |
| 2018-03-31 | $434k | 2.7k | 163.08 |
| 2017-12-31 | $310k | 2.1k | 150.05 |
| 2017-09-30 | $640k | 4.2k | 152.30 |
| 2017-06-30 | $240k | 1.9k | 129.10 |
| 2015-12-31 | $287k | 2.3k | 126.52 |
| 2014-12-31 | $58k | 484 | 119.83 |
| 2014-06-30 | $7.2k | 76 | 94.64 |
More positions owned by National Asset Management
Home Depot (HD)
View all positions for National Asset Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated